These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 965129)

  • 21. Predictors of retention in naltrexone maintenance for opioid dependence: analysis of a stage I trial.
    Sullivan MA; Rothenberg JL; Vosburg SK; Church SH; Feldman SJ; Epstein EM; Kleber HD; Nunes EV
    Am J Addict; 2006; 15(2):150-9. PubMed ID: 16595353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Naltrexone implants as treatment for heroin dependence: part I.
    Byrne A; Graham G; Hallinan R; Murnion B
    Addict Biol; 2005 Jun; 10(2):201; author reply 201-2. PubMed ID: 16191674
    [No Abstract]   [Full Text] [Related]  

  • 23. Naltrexone implants after in-patient treatment for opioid dependence: randomised controlled trial.
    Kunøe N; Lobmaier P; Vederhus JK; Hjerkinn B; Hegstad S; Gossop M; Kristensen Ø; Waal H
    Br J Psychiatry; 2009 Jun; 194(6):541-6. PubMed ID: 19478295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A pilot study to assess the impact of naltrexone implant on accidental opiate overdose in 'high-risk' adolescent heroin users.
    Hulse GK; Tait RJ
    Addict Biol; 2003 Sep; 8(3):337-42. PubMed ID: 13129836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Psychophysiological aspects of the problem of narcotic dependency].
    Tursunkhodzhaev MKh; Tursunkhodzhaeva LA
    Lik Sprava; 2002; (5-6):54-6. PubMed ID: 12442522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical aspects of the use of narcotic antagonists: the state of the art.
    Kleber HD
    Int J Addict; 1977 Oct; 12(7):857-61. PubMed ID: 591143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid heroin detoxification under general anesthesia.
    Laheij RJ; Krabbe PF; de Jong CA
    JAMA; 2000 Mar; 283(9):1143. PubMed ID: 10703775
    [No Abstract]   [Full Text] [Related]  

  • 28. What's happening in hard-drug rehabilitation?
    Walls RT; Gulkus SP
    Rehabil Lit; 1973 Jan; 34(1):2-6. PubMed ID: 4683507
    [No Abstract]   [Full Text] [Related]  

  • 29. Community treatments for heroin and crack cocaine addiction.
    Newman RG; Friedmann P
    Lancet; 2010 Jan; 375(9711):277. PubMed ID: 20109944
    [No Abstract]   [Full Text] [Related]  

  • 30. Add-on gabapentin in the treatment of opiate withdrawal.
    Martínez-Raga J; Sabater A; Perez-Galvez B; Castellano M; Cervera G
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):599-601. PubMed ID: 15093968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Realistic goals for antagonist therapy.
    Martin WR
    Am J Drug Alcohol Abuse; 1975; 2(3-4):353-6. PubMed ID: 1227296
    [No Abstract]   [Full Text] [Related]  

  • 32. METODO, a prospective observational study to assess the efficacy and tolerability of methadone in heroin-addicted patients undergoing a methadone maintenance treatment: preliminary results at baseline evaluation.
    D'Egidio PF; Bignamini E; De Vivo E; Leonardi C; Pieri MC; González-Saiz F; Lucchini A;
    Subst Use Misuse; 2013 Dec; 48(14):1530-40. PubMed ID: 23822738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Five-year follow-up of opiate addicts with naltrexone and behavior therapy.
    Rawson RA; Tennant FS
    NIDA Res Monogr; 1984 Mar; 49():289-95. PubMed ID: 6434974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experiences with an outpatient relapse program (community reinforcement approach) combined with naltrexone in the treatment of opioid-dependence: effect on addictive behaviors and the predictive value of psychiatric comorbidity.
    Roozen HG; Kerkhof AJ; van den Brink W
    Eur Addict Res; 2003 Apr; 9(2):53-8. PubMed ID: 12644730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brokerage model rehabilitation system for opiate dependence: a behavioral analysis.
    Thompson T; Koerner J; Grabowski J
    NIDA Res Monogr; 1984; 46():131-46. PubMed ID: 6427620
    [No Abstract]   [Full Text] [Related]  

  • 36. Narcotic antagonists in the treatment of opioid dependence: review and commentary.
    Resnick RB; Schuyten-Resnick E; Washton AM
    Compr Psychiatry; 1979; 20(2):116-25. PubMed ID: 421447
    [No Abstract]   [Full Text] [Related]  

  • 37. Strategies for preventing heroin overdose.
    Sporer KA
    BMJ; 2003 Feb; 326(7386):442-4. PubMed ID: 12595388
    [No Abstract]   [Full Text] [Related]  

  • 38. [Surprising conclusion by the SBU concerning the benefits of naltrexone in the treatment of heroin dependence].
    Heilig M
    Lakartidningen; 2002 Jan; 99(3):200-4. PubMed ID: 11838078
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of incentives for naltrexone adherence on opiate abstinence in heroin-dependent adults.
    Jarvis BP; Holtyn AF; DeFulio A; Dunn KE; Everly JJ; Leoutsakos JS; Umbricht A; Fingerhood M; Bigelow GE; Silverman K
    Addiction; 2017 May; 112(5):830-837. PubMed ID: 27936293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Buprenorphine versus methadone--safety first?
    Davies D
    Br J Gen Pract; 2005 Mar; 55(512):232-3. PubMed ID: 15808047
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.